MBD2 and gastric cancer: Cross-linking RIP assay revealed endogenous binding of ELAVL1 to intron 1 of MBD2 pre-mRNA in gastric cancer cell lines HGC-27 and AGS, which was attenuated by knockdown of ELAVL1 (Additional file 1: Fig. S1c).